It is very well known that COX-2 induces angiogenesis and lymphangiogenesis through production of VEGFC and VEGFD, and upregulation of PI3K/Akt signalling and COX-2 overexpression can also induce LYVE-1 over expression in mouse breast tumours [28,29]. This evidence concerns the gene AKT1 and breast neoplasm.